| Metric | H1 FY27 | H2 FY26 | H1 FY26 |
|---|---|---|---|
| Revenue from operations | 51.9 | 49.5 | 42.5 |
| Other income | 0.2 | 0.3 | 0.2 |
| Total income | 52.1 | 49.8 | 42.8 |
| Profit before exceptional items & tax | 11.3 | 9.0 | 7.1 |
| Profit before tax | 11.3 | 9.0 | 7.1 |
| Net profit | 7.8 | 6.1 | 5.1 |
| Operating margin | 21.7% | 18.1% | 16.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +52.90% |
|---|---|
| Net profit, quarter on quarter | +27.90% |
| Revenue, year on year | +22.10% |
| Operating profit, year on year | +60.90% |
| Operating profit, quarter on quarter | +27.60% |
BSE results filing, BSE: 544687. Figures extracted from the filing.
Hannah Joseph Hospital Ltd: key numbers
- Share price
- ₹111.10
- Market cap
- ₹252.2 Cr
- Revenue (annual)
- ₹92.05 Cr
- Net profit (annual)
- ₹11.18 Cr
- P/E (TTM)
- 22.6×Sector 54.5×
- Promoter holding
- 71.50%
- FII holding
- 0.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hannah Joseph Hospital Ltd
All →Hannah Joseph Hospital Board Meeting Date
Hannah Joseph Hospital Ltd intimated a Board meeting on 05/11/2026 to approve H1 FY27 unaudited results. The trading window has been closed pending that announcement.
Hannah Joseph Hospital Business Update
Hannah Joseph Hospital received the 'Honours for Healthcare Excellence in Neurosciences' at CII TN MedClave 2026. The award recognises its multidisciplinary Neurosciences services in Tamil Nadu.
Hannah Joseph Hospital Other Announcement
The company filed its quarterly shareholding pattern as mandated by SEBI regulations. This routine disclosure presents the distribution of equity among promoters and public shareholders.
Hannah Joseph Hospital Promoter Buying
Promoter Daniel Dayanand Fenn acquired 2,000 equity shares of Hannah Joseph Hospital Limited through an open market purchase. This transaction increases the total promoter group stake to 71.502%.
- Promoter stake change
- +0.01%
Hannah Joseph Hospital Promoter Buying
Promoter Daniel Dayanand Fenn bought 2,000 open-market Hannah Joseph Hospital shares, raising his stake to 0.053%. A small SAST 29(2) disclosure with no stated transaction price.
- Promoter stake change
- +0.01%
Hannah Joseph Hospital Business Update
Hannah Joseph Hospital Limited received the "Winner" award for "Best Healthcare Digital Initiative" at the 5th CII WR Health Innovation Awards 2026.
- From
- Confederation of Indian Industry (CII)